Multidrug-resistant tuberculosis in Port-au-Prince, Haiti.

Revista Panamericana De Salud Pública = Pan American Journal of Public Health
Oksana OcheretinaDaniel W Fitzgerald

Abstract

To determine the prevalence of multidrug-resistant tuberculosis (MDR-TB) among patients with new smear-positive pulmonary TB in Port-au-Prince, Haiti. Sputum samples were cultured from 1 006 patients newly diagnosed with TB in 2008. The core region of the rpoB gene that is associated with resistance to rifampin was sequenced. All isolates with rpoB mutations were sent to the New York State reference laboratory for conventional drug susceptibility testing (DST). All isolates were also tested with the GenoType MTBDRplus line-probe assay. Mycobacterium tuberculosis was isolated from 906 patients. Twenty-six (2.9%) of the isolates had missense mutations or deletions in rpoB and were resistant to rifampin by DST. All 26 were also resistant to isoniazid and classified as MDR-TB. Forty-six control isolates without rpoB mutations were found to be rifampin sensitive by DST. The GenoType MTBDRplus line-probe assay correctly identified 26 MDR-TB strains. It misclassified one pansusceptible isolate as rifampin resistant. This study shows an MDR-TB prevalence of 2.9% in newly diagnosed TB patients in Haiti and suggests that rpoB sequencing and hybridization assays are good screening tools for early detection of MDR-TB.

References

Sep 1, 1990·The American Review of Respiratory Disease·M ScalciniR Long
Nov 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J L MaloneP J Weiss
Jan 25, 2000·Tubercle and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·S Ramaswamy, J M Musser
Sep 9, 2005·The New England Journal of Medicine·Kevin SchwartzmanDick Menzies
Jan 28, 2006·AIDS·Patrice JosephDaniel W Fitzgerald
Jan 29, 2010·The New England Journal of Medicine·Jean William PapeDaniel W Fitzgerald

❮ Previous
Next ❯

Citations

Jan 1, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jean W PapeWarren D Johnson
Oct 19, 2013·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·J R SchwartzbordD L Brown
Jul 30, 2014·The American Journal of Tropical Medicine and Hygiene·Macarthur CharlesJean W Pape
Jun 9, 2020·Tropical Medicine & International Health : TM & IH·Fátima M TenganWanderley M Bernardo
Mar 19, 2021·PloS One·Jonathan HoffmannJean William Pape

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.